Management of diabetic ketoacidosis and hyperglycemic hyperosmolar state in adults

References

• Centers for Disease Control and Prevention, Department of Health and Human Services: Diabetes Data & Trends. Crude and age-adjusted hospital discharge rates for diabetic ketoacidosis as first-listed diagnosis per 1,000 diabetic population, United States, 1988–2009; [ cited 2013 Jan]. Available from: http://www.cdc.gov/diabetes/statistics/dkafirst/
   Google Scholar
• Davis SN, Umpierrez GE. Diabetic ketoacidosis in type 2 diabetes mellitus–pathophysiology and clinical presentation. Nat Clin Pract Endocrinol Metab. 2007;3(11):730–731.
   PubMedGoogle Scholar
• Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001;24(1):131–153.
   PubMed Web of Science ®Google Scholar
• Ennis ED, Stahl EJVB, Kreisberg RA. The hyperosmolar hyperglycemic syndrome. Diabetes Rev. 1994;2:115–126.
   Google Scholar
• Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–1343.
   PubMed Web of Science ®Google Scholar
• Basu A, Close CF, Jenkins D, et al. Persisting mortality in diabetic ketoacidosis. Diabet Med. 1993;10(3):282–284.
   PubMed Web of Science ®Google Scholar
• Savage MW, Dhatariya KK, Kilvert A, et al. Joint British diabetes societies guideline for the management of diabetic ketoacidosis. Diabet Med. 2011;28(5):508–515.
   PubMed Web of Science ®Google Scholar
• Otieno CF, Kayima JK, Omonge EO, et al. Diabetic ketoacidosis: risk factors, mechanisms and management strategies in sub-Saharan Africa: a review. East Afr Med J. 2005;82(12 Suppl):S197–S203.
   PubMedGoogle Scholar
• Wachtel TJ, Silliman RA, Lamberton P. Prognostic factors in the diabetic hyperosmolar state. J Am Geriatr Soc. 1987;35(8):737–741.
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Kelly JP, Navarrete JE, et al. Hyperglycemic crises in urban blacks. Arch Intern Med. 1997;157(6):669–675.
   PubMedGoogle Scholar
• Javor KA, Kotsanos JG, McDonald RC, et al. Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care. 1997;20(3):349–354.
   PubMed Web of Science ®Google Scholar
• Foster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med. 1983;309(3):159–169.
   PubMed Web of Science ®Google Scholar
• van de Werve G, Jeanrenaud B. Liver glycogen metabolism: an overview. Diabetes Metab Rev. 1987;3(1):47–78.
   PubMedGoogle Scholar
• DeFronzo RA, Matzuda M, Barret E. Diabetic ketoacidosis: a combined metabolic-nephrologic approach to therapy. Diabetes Rev. 1994;2:209–238.
   Google Scholar
• McGarry JD, Woeltje KF, Kuwajima M, et al. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab Rev. 1989;5(3):271–284.
   PubMed Web of Science ®Google Scholar
• Gerich JE, Martin MM, Recant L. Clinical and metabolic characteristics of hyperosmolar nonketotic coma. Diabetes. 1971;20(4):228–238.
   PubMed Web of Science ®Google Scholar
• Thuzar M, Malabu UH, Tisdell B, et al. Use of a standardised diabetic ketoacidosis management protocol improved clinical outcomes. Diabetes Res Clin Pract. 2014;104(1):e8–e11.
   PubMed Web of Science ®Google Scholar
• Weinert LS, Scheffel RS, Severo MD, et al. Precipitating factors of diabetic ketoacidosis at a public hospital in a middle-income country. Diabetes Res Clin Pract. 2012;96(1):29–34.
   PubMed Web of Science ®Google Scholar
• Tan H, Zhou Y, Yu Y. Characteristics of diabetic ketoacidosis in Chinese adults and adolescents – a teaching hospital-based analysis. Diabetes Res Clin Pract. 2012;97(2):306–312.
   PubMed Web of Science ®Google Scholar
• Suwarto S, Sutrisna B, Waspadji S, et al. Predictors of five days mortality in diabetic ketoacidosis patients: a prospective cohort study. Acta Med Indones. 2014;46(1):18–23.
   PubMedGoogle Scholar
• Barski L, Nevzorov R, Rabaev E, et al. Diabetic ketoacidosis: clinical characteristics, precipitating factors and outcomes of care. Isr Med Assoc J. 2012;14(5):299–303.
   PubMed Web of Science ®Google Scholar
• Ko SH, Lee WY, Lee JH, et al. Clinical characteristics of diabetic ketoacidosis in Korea over the past two decades. Diabet Med. 2005;22(4):466–469.
   PubMed Web of Science ®Google Scholar
• Edo AE. Clinical profile and outcomes of adult patients with hyperglycemic emergencies managed at a tertiary care hospital in Nigeria. Niger Med J. 2012;53(3):121–125.
   PubMedGoogle Scholar
• Guisado-Vasco P, Cano-Megias M, Carrasco-de la Fuente M, et al. Clinical features, mortality, hospital admission, and length of stay of a cohort of adult patients with diabetic ketoacidosis attending the emergency room of a tertiary hospital in Spain. Endocrinol Nutr. 2015;62(6):277–284.
   PubMed Web of Science ®Google Scholar
• Alourfi Z, Homsi H. Precipitating factors, outcomes, and recurrence of diabetic ketoacidosis at a university hospital in Damascus. Avicenna J Med. 2015;5(1):11–15.
   PubMedGoogle Scholar
• Lin S-F, Lin J-D, Huang Y-Y. Diabetic ketoacidosis: comparisons of patient characteristics, clinical presentations and outcomes today and 20 years ago. Chang Gung Med J. 2005;28(1):24–30.
   PubMedGoogle Scholar
• Randall L, Begovic J, Hudson M, et al. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care. 2011;34(9):1891–1896.
   PubMed Web of Science ®Google Scholar
• Wolfsdorf J, Craig ME, Daneman D, et al. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diabetes. 2009;10(Suppl 12):118–133.
   PubMed Web of Science ®Google Scholar
• Barnard KD, Skinner TC, Peveler R. The prevalence of co-morbid depression in adults with type 1 diabetes: systematic literature review. Diabet Med. 2006;23(4):445–448.
   PubMed Web of Science ®Google Scholar
• Goguen J, Gilbert J. Canadian diabetes association clinical practice guidelines expert. Hyperglycemic emergencies in adults. Can J Diabetes. 2013;37(Suppl 1):S72–S76.
   PubMed Web of Science ®Google Scholar
• Peters AL, Buschur EO, Buse JB, et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687–1693.
   PubMed Web of Science ®Google Scholar
• Taylor SI, Blau JE, Rother KI. Perspective: SGLT2 inhibitors may predispose to ketoacidosis. J Clin Endocrinol Metab. 2015;100(8):2849–2852.
   Web of Science ®Google Scholar
• Ferrannini E, Muscelli E, Frascerra S, et al. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest. 2014;124(2):499–508.
   PubMed Web of Science ®Google Scholar
• Umpierrez G, Freire AX. Abdominal pain in patients with hyperglycemic crises. J Crit Care. 2002;17(1):63–67.
   PubMed Web of Science ®Google Scholar
• Stephens JM, Sulway MJ, Watkins PJ. Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes. Diabetes. 1971;20(7):485–489.
   PubMed Web of Science ®Google Scholar
• Freire AX, Umpierrez GE, Afessa B, et al. Predictors of intensive care unit and hospital length of stay in diabetic ketoacidosis. J Crit Care. 2002;17(4):207–211.
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Kitabchi AE. Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol. 2003;2(2):95–108.
   PubMedGoogle Scholar
• Adrogue HJ, Wilson H, Boyd AE 3rd, et al. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med. 1982;307(26):1603–1610.
   PubMed Web of Science ®Google Scholar
• Oh MS, Carroll HJ, Uribarri J. Mechanism of normochloremic and hyperchloremic acidosis in diabetic ketoacidosis. Nephron. 1990;54(1):1–6.
   PubMed Web of Science ®Google Scholar
• Luzi L, Barrett EJ, Groop LC, et al. Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes. 1988;37(11):1470–1477.
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004;117(5):291–296.
   PubMed Web of Science ®Google Scholar
• Ersoz HO, Ukinc K, Kose M, et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. Int J Clin Pract. 2006;60(4):429–433.
   PubMed Web of Science ®Google Scholar
• Karoli R, Fatima J, Salman T, et al. Managing diabetic ketoacidosis in non-intensive care unit setting: role of insulin analogs. Indian J Pharmacol. 2011;43(4): 398–401.
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Cuervo R, Karabell A, et al. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care. 2004;27(8):1873–1878.
   PubMed Web of Science ®Google Scholar
• Della Manna T, Steinmetz L, Campos PR, et al. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care. 2005;28(8):1856–1861.
   PubMed Web of Science ®Google Scholar
• Zipf WB, Bacon GE, Spencer ML, et al. Hypocalcemia, hypomagnesemia, and transient hypoparathyroidism during therapy with potassium phosphate in diabetic ketoacidosis. Diabetes Care. 1979;2(3):265–268.
   PubMedGoogle Scholar
• Winter RJ, Harris CJ, Phillips LS, et al. Diabetic ketoacidosis. Induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Med. 1979;67(5): 897–900.
   PubMed Web of Science ®Google Scholar
• Fadini GP, de Kreutzenberg SV, Rigato M, et al. Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. Diabetes Res Clin Pract. 2011;94(2):172–179.
   PubMed Web of Science ®Google Scholar
• Hsia E, Seggelke S, Gibbs J, et al. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab. 2012;97(9):3132–3137.
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Jones S, Smiley D, et al. Insulin analogs versus human insulin in the treatment of patients controlled trial. Diabetes Care. 2009;32(7):1164–1169.
   PubMed Web of Science ®Google Scholar
• Laffel L. Sick-day management in type 1 diabetes. Endocrinol Metab Clin North Am. 2000;29(4):707–723.
   PubMed Web of Science ®Google Scholar
• Jefferies CA, Nakhla M, Derraik JG, et al. Preventing diabetic ketoacidosis. Pediatr Clin North Am. 2015;62(4):857–871.
   PubMed Web of Science ®Google Scholar
• Vanelli M, Chiari G, Ghizzoni L, et al. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care. 1999;22(1):7–9.
   PubMed Web of Science ®Google Scholar